Wound-healing spray moves to Phase III clinical trials

04/16/2013 | WTAJ-TV (Altoona, Pa.)

Patients are being recruited for Phase III clinical trials of a spray containing human cells that release growth factors into a wound to encourage tissue regeneration. Wounds treated with the spray were 52% more likely to heal than those treated with compression bandages in earlier trials.

View Full Article in:

WTAJ-TV (Altoona, Pa.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC